HOMEVULNERABILITIESCVE-2023-26913
MEDIUM

CVE-2023-26913

CWE-79Published: March 22, 2023· Updated: Jun 17, 2026

6.1
CVSS v3.1

Official Description

EVOLUCARE ECSIMAGING (aka ECS Imaging) < 6.21.5 is vulnerable to Cross Site Scripting (XSS) via new_movie. php.

NVD Source

Technical Analysis

CVE-2023-26913 can be exploited remotely over the network without requiring physical or adjacent access, significantly expanding the attack surface for threat actors.

Exploitation does not require any privileges, though user interaction (Required) is needed, which slightly reduces the risk of mass automated attacks.

The vulnerability has a "Changed" scope, meaning successful exploitation can impact components beyond the vulnerable component itself — such as the host operating system or adjacent services.

From a weakness classification perspective (CWE-79): Cross-site scripting (XSS) vulnerabilities allow attackers to inject malicious scripts into web pages viewed by other users.

CVSS v3.1 Vector Breakdown

Exploitability
Attack VectorNetwork
Attack ComplexityLow
Privileges Req.None
User InteractionRequired
ScopeChanged
Impact
ConfidentialityLow
IntegrityLow
AvailabilityNone
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N

Affected Vendors & Products

evolucare1 product(s)
ecs imaging
Source: NVD CPE · 1 total CPE entries

Exploit & PoC Resources

NO KNOWN EXPLOITNo public exploit confirmed at this time
External links open in a new tab. Always verify in a controlled environment before use.

Official Patches & Advisories

All References (2)

Quick Facts

CVE IDCVE-2023-26913
CVSS Score6.1 / 10
SeverityMEDIUM
WeaknessCWE-79
CISA KEVNo
Affected1 vendor(s)
PublishedMar 22, 2023

Related CVEs (CWE-79)

Recommended Actions

  • Apply vendor patches immediately
  • Monitor CVE-2023-26913 in threat intel feeds
  • Review IDS/IPS signatures for exploitation attempts
Data sourced from NVD (NIST), CISA KEV, and EPSS (FIRST). Analysis generated by CTIWatch. CVE data is provided under the NVD usage policy.